We are live on ! Find out more
BCM

Becker Capital Management Portfolio holdings

AUM $3.4B
1-Year Est. Return 24.68%
This Fund
S&P 500
This Quarter Est. Return
+7.48%
1 Year Est. Return
+24.68%
3 Year Est. Return
+71.53%
5 Year Est. Return
+96.62%
10 Year Est. Return
+273.67%
AUM
$2.18B
AUM Growth
+$199M
Cap. Flow
+$58.8M
Cap. Flow %
2.7%
Top 10 Hldgs %
21.15%
Holding
133
New
10
Increased
54
Reduced
40
Closed
3

Top Sells

Rank Stock Value
1
TECK icon
Teck Resources
TECK
+$25.4M
2
BSX icon
Boston Scientific
BSX
+$11.5M
3
AMGN icon
Amgen
AMGN
+$10.9M
4
LHX icon
L3Harris
LHX
+$9.18M
5
TAP icon
Molson Coors Class B
TAP
+$8.94M

Sector Composition

Rank Sector Weight
1 Industrials 16.43%
2 Technology 16.14%
3 Financials 16.01%
4 Energy 13.77%
5 Healthcare 12.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KSS icon
26
Kohl's
KSS
$1.96B
$31.1M 1.43%
601,856
+10,940
+2% +$571K
WMT icon
27
Walmart Inc
WMT
$909B
$30.7M 1.41%
1,246,965
+54,405
+5% +$1.37M
TEVA icon
28
Teva Pharmaceuticals
TEVA
$37.3B
$29.9M 1.37%
+790,242
New +$30.8M
USB icon
29
US Bancorp
USB
$98.4B
$29.7M 1.36%
811,601
+25,540
+3% +$946K
SPLS
30
DELISTED
Staples Inc
SPLS
$29.6M 1.36%
2,017,650
+62,080
+3% +$973K
HP icon
31
Helmerich & Payne
HP
$3.41B
$29.1M 1.33%
421,487
+10,760
+3% +$710K
GLW icon
32
Corning
GLW
$133B
$29M 1.33%
1,984,780
+77,200
+4% +$1.14M
T icon
33
AT&T
T
$152B
$28.9M 1.33%
1,133,098
+79,820
+8% +$2.1M
CTSH icon
34
Cognizant
CTSH
$21.2B
$28.9M 1.33%
703,340
+42,000
+6% +$1.56M
SLB icon
35
SLB Ltd
SLB
$70.3B
$28.6M 1.31%
324,122
+857
+0.3% +$70.4K
HHH icon
36
Howard Hughes
HHH
$4.19B
$28.6M 1.31%
267,114
+40,271
+18% +$4.21M
TEL icon
37
TE Connectivity
TEL
$59.3B
$28.5M 1.31%
549,635
-27,416
-5% -$1.37M
LLL
38
DELISTED
L3 Technologies, Inc.
LLL
$28.4M 1.3%
300,005
-1,190
-0.4% -$110K
COV
39
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$28M 1.28%
459,344
-42,436
-8% -$2.59M
MUR icon
40
Murphy Oil
MUR
$5.28B
$27M 1.24%
448,258
-65,926
-13% -$3.88M
CVX icon
41
Chevron
CVX
$373B
$27M 1.24%
221,939
+6,053
+3% +$744K
FDX icon
42
FedEx
FDX
$74.7B
$26.5M 1.21%
231,982
-40,431
-15% -$4.36M
MS icon
43
Morgan Stanley
MS
$339B
$26.5M 1.21%
981,615
+12,960
+1% +$348K
XEL icon
44
Xcel Energy
XEL
$49.2B
$25.7M 1.18%
932,002
+177,285
+23% +$5.07M
AMGN icon
45
Amgen
AMGN
$198B
$25.7M 1.18%
229,703
-100,165
-30% -$10.9M
LHX icon
46
L3Harris
LHX
$52.5B
$25.2M 1.16%
425,779
-164,902
-28% -$9.18M
HSP
47
DELISTED
HOSPIRA INC
HSP
$24.3M 1.12%
620,830
-2,855
-0.5% -$114K
BG icon
48
Bunge Global
BG
$23.1B
$24.3M 1.12%
320,413
+26,525
+9% +$2.01M
HMC icon
49
Honda
HMC
$36.5B
$23.8M 1.09%
624,238
+21,520
+4% +$822K
PPLI
50
People Inc
PPLI
$3.31B
$23.6M 1.08%
+2,418,039
New +$22.1M

Similar funds

Becker Capital Management's Q3 2013 Portfolio in Review

As of Q3 2013, Becker Capital Management held 133 positions worth $2.18B, up 10% from $1.98B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Becker Capital Management's Q3 2013 filing shows 10 new, 54 increased, 40 reduced and 3 closed positions. Its largest new stake was Teva Pharmaceuticals: 790,242 shares worth $29.9M. The largest sale was Teck Resources, an estimated $25.4M.

By sector, the portfolio is most concentrated in Industrials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • Becker Capital Management's largest Q3 2013 buy was Teva Pharmaceuticals: 790,242 shares worth $29.9M.
  • Becker Capital Management added most to PLUM CREEK TIMBER CO (REIT) in Q3 2013, an estimated $7.44M increase.
  • Becker Capital Management's biggest Q3 2013 reduction was Boston Scientific, cutting an estimated $11.5M.
  • Becker Capital Management fully exited Teck Resources in Q3 2013, selling an estimated $25.4M.
  • Becker Capital Management's ten largest holdings make up 21% of its $2.18B portfolio in Q3 2013.
  • Becker Capital Management opened 10 new positions and closed 3 in Q3 2013.
  • Becker Capital Management's portfolio value rose 10% quarter-over-quarter to $2.18B.

Based on Becker Capital Management's 13F filing for Q3 2013, filed 12 Nov 2013.